Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
RxSight's peak revenue was $139.9M in 2024. The peak quarterly revenue was $40.2M in 2024(q4).
RxSight's revenue increased from $14.7m in 2020 to $139.9M currently. That's a 853.31% change in annual revenue.
| Fiscal year / year | RxSight revenue |
|---|---|
| 2020 | $14.7M |
| 2021 | $22.6M |
| 2022 | $49.0M |
| 2023 | $89.1M |
| 2024 | $139.9M |
How accurately did RxSight's revenue projections match actual performance?
RxSight saw the greatest revenue growth in 2022, when revenue increased by 116.9%.
RxSight had the lowest revenue growth in 2021, when revenue changed by 53.92%.
| Year | RxSight growth |
|---|---|
| 2021 | 54%↑ |
| 2022 | 117%↑ |
| 2023 | 82%↑ |
| 2024 | 57%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | $5.8M | $8.4M |
| 2022 | $8.9M | $11.4M | $12.6M | $16.1M |
| 2023 | $17.5M | $20.8M | $22.2M | $28.6M |
| 2024 | $29.5M | $34.9M | $35.3M | $40.2M |
Do you work at RxSight?
Did RxSight meet its revenue projections?
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 148 |
| Date Founded | 1997 |
| Headquarters | Aliso Viejo, California |
| Number of Locations | 1 |
| Revenue | $139.9M |
| Net Income | -$66,756,000 |
| Gross Proft | $98.9M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $150,164,000 |
| Ticker | RXST |
RxSight received early financing of $8.5M on 2010-08-27.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $8.5M | 08/2010 |
| Series Unknown | $5.1M | 10/2011 |
| Series Unknown | $12.7M | 03/2014 |
| Series Unknown | $52M | 06/2015 |
| Debt Financing | $17M | 06/2015 |
| Series H | $21M | 03/2017 |
| Series Unknown | $9.6M | 04/2020 |
| Debt Financing | $60M | 12/2020 |
| Investors | Security type |
|---|---|
| H.I.G. BioHealth Partners | Series Unknown |
| Balance Point Capital Partners | Series Unknown |
| Longitude Capital | Series Unknown |
| RA Capital Management | Series Unknown |
| H.I.G. BioHealth Partners | Debt Financing |
| Balance Point Capital Partners | Debt Financing |
| Longitude Capital | Debt Financing |
| RA Capital Management | Debt Financing |
| Visionary Venture Fund | Series H |
| Biomedical Advanced Research and Development Authority (BARDA) | Series Unknown |
| Oxford Finance LLC | Debt Financing |
| Armentum Partners | Debt Financing |
Zippia gives an in-depth look into the details of RxSight, including salaries, political affiliations, employee data, and more, in order to inform job seekers about RxSight. The employee data is based on information from people who have self-reported their past or current employments at RxSight. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by RxSight. The data presented on this page does not represent the view of RxSight and its employees or that of Zippia.
RxSight may also be known as or be related to RxSight, RxSight Inc and RxSight, Inc.